CAMP4 Therapeutics Corporation (CAMP) |
| 4.15 0.01 (0.24%) 08-28 16:00 |
| Open: | 4.17 |
| High: | 4.3 |
| Low: | 4.04 |
| Volume: | 142,058 |
| Market Cap: | 88(M) |
| PE Ratio: | -1.76 |
| Exchange: | NASDAQ Global Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 6.00 |
| Resistance 1: | 4.92 |
| Pivot price: | 4.51 |
| Support 1: | 3.16 |
| Support 2: | 2.63 |
| 52w High: | 7.75 |
| 52w Low: | 1.41 |
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
Financials
| EPS | -2.310 |
| Book Value | -0.010 |
| PEG Ratio | 0.00 |
| Gross Profit | -0.549 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -752.11 |
| Return on Assets (ttm) | -45.3 |
| Return on Equity (ttm) | -545.8 |
Company news
Thu, 27 Aug 2026
Camp4 Therapeutics director Andrew Schwab sells $45 in shares - Investing.com
Wed, 19 Aug 2026
Camp4 Therapeutics (NASDAQ: CAMP) insider to sell 1,738 shares - Stock Titan
Wed, 19 Aug 2026
Camp4 Therapeutics (NASDAQ: CAMP) backer sees stake diluted after new share sales - Stock Titan
Sat, 15 Aug 2026
Analysts’ Top NA Picks: CAMP4 Therapeutics Corporation (CAMP), Wayfair (W) - The Globe and Mail
Thu, 13 Aug 2026
Calamp Corp. (CAMP) News, Articles, Events & Latest Updates - Stocktwits
Thu, 13 Aug 2026
CAMP4 Therapeutics Corporation (CAMP) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
